Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck

Summary

The purpose of this research study is to test the safety of a chemotherapy drug called docetaxel and focused radiation therapy (SBRT) and see what effects (good and bad) it has on recurrent head and neck cancer that is not surgically removable.

Timeline

Start

2014-04

Primary completion

2017-03-29

Completion

2017-03-29

Outcome

Outcome not reported

Stopped (Enrollment): “slow accrual”

Drugs

Indications